Roberto Manfredi, Sergio Sabbatani, Leonardo Calza
Department of Clinical and Experimental Medicine, Division of Infectious Diseases, University of Bologna Alma Mater Studiorum, S Orsola-Malpighi Hospital, Bologna, Italy

This report is of a patient with Candida albicans panopthalmitis, probably prompted by a decompensated underlying diabetes mellitus. The clinical course was prolonged (more than 16 weeks), although favourable after treatment with antifungal agents with a predictable activity in this condition and proven susceptibility to Candida albicans. This report will discuss the treatment of Candida albicans panophthalmitis and
review the literature.

Key words: Amphotericin B, Antifungal agents, Candida albicans, Caspofungin, Fluconazole, Panophthalmitis, Voriconazole

Asian J Ophthalmol. 2007;9:182-184.